ArticleHealth economics review2013

Cost analysis of glatiramer acetate vs. fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain.

Rainel Sanchez-de la Rosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.